What did @ilonabevi actually say?
Here's the honest answer: the transcript contains no medical claims at all. The spoken audio is song lyrics, not health advice. The actual substance comes entirely from the caption, which promotes something called "GLOW 70" and names three peptides: GHK-Cu for "skin and hair," and TB-500 plus BPC-157 for "recovery." The creator then invites followers to comment "START" to receive more information, which is a common DM-funnel tactic used to promote telehealth or supplement products outside of public view.
This structure matters for fact-checking. The video itself makes no spoken claims, but the caption does real work, naming specific peptides, attributing specific benefits, and directing users toward a product or service. That's enough to evaluate. The "not medical advice" disclaimer at the bottom does not change what the caption is functionally doing.
Does the science back this up?
Partially, and with significant caveats. GHK-Cu has the strongest evidence of the three, TB-500 has promising but mostly preclinical data, and BPC-157 is the most overhyped relative to what human trials actually show.
GHK-Cu (copper peptide) has been studied in human skin contexts. Pickart and Margolina (2018, Cosmetics) reviewed evidence showing GHK-Cu stimulates collagen synthesis, has antioxidant properties, and may support hair follicle health. These are real findings, though most robust data comes from in vitro or small clinical studies, not large randomized controlled trials. Calling it a "skin and hair" peptide is not wildly inaccurate, but it is optimistic framing.
TB-500 (a synthetic fragment of Thymosin Beta-4) shows wound healing and anti-inflammatory effects in animal models. Goldstein et al. have published extensively on Thymosin Beta-4, but human clinical trial data for TB-500 specifically is thin. Claiming it supports "recovery" in humans is plausible but extrapolated well beyond current evidence.
BPC-157 has shown gut repair and tendon healing effects in rodent studies (Sikiric et al., multiple publications in journals including Current Pharmaceutical Design), but zero completed, peer-reviewed human RCTs exist for recovery applications as of early 2025. The gap between rat models and human outcomes is enormous here.
What did they get wrong (or right)?
The GHK-Cu framing is defensible. The evidence base is real, even if modest. Credit where it's due.
The TB-500 and BPC-157 "recovery" framing is where this slides into misleading territory. Presenting these as established recovery tools implies a level of human evidence that does not exist. The DM-funnel format, asking users to comment "START" for more info, is a known pattern for directing people toward compounded peptide products that exist in a regulatory gray zone. The FDA has flagged BPC-157 as not eligible for compounding under 503A and 503B, which means any compounded BPC-157 product is operating outside FDA authorization.
The "not medical advice" disclaimer is doing a lot of heavy lifting for a caption that names specific peptides, specific benefits, and invites personalized outreach. Disclaimers do not neutralize functional medical claims.
What should you actually know?
These are not vitamins. GHK-Cu, TB-500, and BPC-157 are bioactive peptides with real physiological effects, which means they also carry real risks, particularly around sourcing, purity, and dosing, none of which can be assessed from a TikTok caption.
Regulatory status is the part most creators skip. The FDA placed BPC-157 on its list of substances that cannot be compounded for human use. That means if someone is selling or prescribing compounded BPC-157 through a DM funnel, that product lacks FDA oversight on purity and potency. That is not a small footnote.
If you are genuinely interested in peptide therapy, the path that involves the least risk is a licensed clinician who can review your full health history, order appropriate labs, and prescribe through a legitimate 503B compounding pharmacy. A TikTok DM is not that path.
- Ask any telehealth platform about their prescribing clinician credentials before purchasing
- Ask specifically which compounding pharmacy they use and whether it is PCAB-accredited
- Be skeptical of any platform that bundles multiple peptides into a named product without transparent ingredient sourcing